Obesity Weight Loss
Drugs Guidelines, Xenical, Meridia
About Obesity Medications
Obesity Drugs Guidelines
People who are seriously overweight should only be given anti-obesity drugs if they are prepared to diet and exercise, say doctors. A report by the Royal College of Physicians (RCP) also suggests that patients should be taken off the drugs if they fail to lose enough weight.
Obesity levels across Britain have jumped sharply over the past 20 years. An estimated 55 percent of people are now either overweight or clinically obese. More and more patients are being prescribed anti-obesity drugs in an attempt to tackle the problem.
However, guidelines from the RCP warn doctors that these drugs should not be seen as a "quick fix". The report states: "It is important to avoid offering anti-obesity drug therapy to patients who are seeking a 'quick fix' for the weight problem."
"Not all obese patients respond to drug therapy," the report says.
Professor Peter Kopelman, chairman of the RCP's nutrition committee which drew up the report, said the guidelines would help doctors decide who should receive the drugs.
"The report provides up-to-date guidance for all medical practitioners about the appropriate use of anti-obesity drugs for the management of overweight and obese patients," he said.
"It places the prescription of such drugs into the context of good medical practice and makes strong recommendations about the initiation of treatment and follow-up arrangements for patients."
More Britons are now clinically obese than ever before. In 1980, 6 percent of men and 8 percent of women were obese. In 2000, that figure had jumped to 21 percent for both sexes.
Doctors blame changes in lifestyle for the rise. People are now eating more fatty foods and they are also exercising less.
They have warned of a huge rise in obesity-related diseases, including diabetes and heart disease, unless people start to lose weight. Over 30,000 deaths a year are caused by obesity in England alone.
The National Institute for Clinical Excellence approved the use of new anti-obesity drugs on the NHS in 2001.
Experts at the drugs watchdog said the benefits of the drugs outweighed the costs to the health service.
Source: BBC health 2002
ACC2 Weight Loss Enzyme - Appetite Suppressant Drugs - Health Risks Appetite Suppressant - Appetite Suppressants Weight Loss - Axokine Diet Drug - C75 Weight Loss Compound - Cholecystokinin Weight Loss - Dexfenfluramine Weight Loss - Didrex Diet Drugs - Depression Diet Drugs - Diet Drugs Usage - Diet Drugs - Diet Pills Eating Exercise - Diet Pills Weight Regain - Weight Loss Drugs Diet Program - Fen Phen - Fenfluramine Weight Loss Drugs - Fluoxetine Weight Loss - GIP Hormone Weight Loss Drug - Ionamin Diet Drugs - KB-141 Weight Loss Compound - Meridia Diet Drugs - Meridia Weight Loss Drug Ban - New Weight Loss Drugsl - Obesity Drugs Guidelines - Obesity Prescription Drug Markets - Obesity Weight Loss Drugs Treatment - Orlistat Lipase Inhibitor - Orlistat Drug Treatment Obesity - Anti-Obesity Drugs Trial Orlistat & Sibutramine - Orlistat Glucose Study - Orlistat Weight Management Advice - Orlistat Unsatisfactory Weight Reduction - Orlistat / Xenical Pills Weight Reduction - Phentermine Appetite Lowering Diet Drugs - Phentermine Weight Loss Drugs - Phenylpropanolamine (PPA) Weight Loss Drug - Prescription Drugs Treatment of Obesity - Sibutramine Binge Eating - Comparison Sibutramine Dexfenfluramine - Sibutramine Health Safety - Sibutramine Energy Weight Management - Sibutramine Abuse - Sibutramine Weight Loss Trial - Sibutramine Weight Loss Drugs - Tenuate Diet Drugs - Topiramate Anti-Obesity Drug - Weight Loss Drug Therapy - Weight Loss Drugs Review - Weight Loss Medication Candidate Evaluation - Weight Loss Medications Guidelines - Weight Loss Anti-Obesity Drugs - Weight Loss Study Orlistat - Weight Loss Pills Overdose - Minimize Health Risks Weight Loss Pills - Weight Loss Pills Do They Work? - Weight Management Drugs Advice - Zenical Weight Loss Drug